Measuring the suffering of end-stage dementia: reliability and validity of the Mini-Suffering State Examination

https://doi.org/10.1016/j.archger.2003.08.007Get rights and content

Abstract

Assessment of suffering is extremely important in dying end-stage dementia patients (ESDP). We have developed and examined the reliability and validity of the Mini-Suffering State Examination (MSSE), in 103 consecutive bedridden ESDP. Main outcome measures included inter-observer reliability and concurrent validity. Reliability of the MSSE questionnaire was satisfactory, with Cronbach α values of 0.735 and 0.718 for the two physicians (Ph-1, Ph-2), respectively. The κ agreement coefficient was 0.791. There was a high agreement for seven items (κ 0.882–0.972) and a substantial agreement for the other three items (κ 0.621–0.682) of the MSSE. MSSE was validated versus the comfort assessment in dying with dementia (CAD-EOLD) scale and resulted in a significant Pearson correlation (r=−0.796, P<0.001). We conclude that the MSSE scale is a reliable and valid clinical tool, recommended for evaluating the severity of the patient’s condition and the level of suffering of ESDP. Use of MSSE may improve medical management and facilitate communication between patients and caregivers.

Introduction

Suffering and satisfaction are two basic sensations, perceptions, emotions and thoughts of any human being, and coping with suffering or fear of suffering at the end-of-life is part of everyone’s life-cycle. The concept of suffering has been well described (Cassel, 1982) and encompasses, at a minimum, aspects of physical pain, psychological distress and spiritual concerns. Levels of suffering are believed to increase with aging and the various losses associated with getting older. Old people at end-of-life may be too demented to communicate their needs, understand treatment options or articulate emotional needs about the dying process (Siegler and Levin, 2000). Medical and nursing staffs are expected to diagnose symptoms and syndromes of disease, but not necessarily to be aware of the suffering of the patient (Cassel, 1999). This may undermine the caregiver’s ability to accurately assess the patient’s needs. Various aspects of end-of-life for patients with advanced dementia have been discussed, yet issues of suffering and the appropriate health care for such patients remain controversial (Luchins and Hanrahan, 1993, Hurley et al., 2000). The nature of suffering makes it difficult to assess, and there have been no reports in the medical literature on methods of examining the level of suffering. This is in contrast with various clinical instruments designed to measure quality of life or satisfaction with care at end-of-life. Moreover, the suffering of end-stage dementia patients (ESDP) is often accompanied by inability to verbally indicate the extent of suffering. The assessment of suffering is crucial for its alleviation, and becomes critical once options of physician-assisted suicide and euthanasia are considered (Fins and Bachetta, 1995).

The purpose of this study is to evaluate the inter-observer reliability and validity of a clinically-based tool designed to evaluate suffering of ESDP by means of the Mini-Suffering State Examination (MSSE) (Aminoff, 1999) (Table 1).

Section snippets

Study participants

We studied consecutive ESDP treated in our center during a 12 months period. Diagnosis was based upon the DSM-4 revised criteria for dementia (American Psychiatric Association, 1994). Inclusion criteria included severe dementia interfering with verbal communication (Mini-Mental State Examination 0/30) (Folstein et al., 1975) and complete dependence in activities of daily living and functional movement activities (Functional Independence Measure 18/126) (Granger and Hamilton, 1992). We included

Results

Total MSSE scores were 4.8±2.5 and 4.4±2.4 (Ph-1 and Ph-2, respectively), resulting in a high level Pearson’s correlation between physicians (r=0.929). Cronbach α coefficients of MSSE were 0.735 and 0.718, thus, supporting its reliability. A κ agreement coefficient of 0.791 between Ph-1 and Ph-2 was found. A high-level agreement coefficient was found between the two physicians on seven out of the 10 items on the MSSE scale (κ 0.882–0.972), and substantial for three of the items (κ 0.620–0.682) (

Discussion

Between 2.5 and 4 millions US residents have Alzheimer disease or related dementia that will ultimately require end-of-life care. Many are expected to spend the last phase of life in various settings of palliative care, where issues of quality of care and satisfaction of patients and families are of crucial importance. Defining and measuring these aspects is difficult but undoubtedly important (Teno et al., 1997), however, this does not necessarily help us to evaluate the suffering of a

Acknowledgements

We thank the medical and nursing staff of the Department of Geriatric Medicine, and Mrs. Birnhack Juliette for her assistance in the preparation of this paper.

References (19)

  • M.F. Folstein et al.

    Mini-mental state: a practical method for grading the cognitive state of patients for the clinician

    J. Psychiatr. Res.

    (1975)
  • L. Volicer

    Management of severe Alzheimer Disease and end-of-life issues

    Clin. Geriatr. Med.

    (2001)
  • AGS Ethics Committee, 1995. The care of the dying patients: a position statement from the American Geriatrics Society....
  • American Psychiatric Association, 1994. Diagnostic and Statistical Manual of Mental Disorders, fourth ed. American...
  • Aminoff, B.Z., 1999. Mini Suffering State Examination (Abstract). Fourth European Congress of Gerontology, Book of...
  • Canadian Palliative Care Association, 1995. Palliative care: towards a consensus in standardized principles and...
  • E.J. Cassel

    The nature of suffering and the goals of medicine

    N. Eng. J. Med.

    (1982)
  • E.J. Cassel

    Diagnosing suffering: a perspective

    Ann. Int. Med.

    (1999)
  • J.I. Fins et al.

    Framing the physician-assisted suicide and voluntary active euthanasia debate: the role of deontology, consequentialism and clinical pragmatism

    J. Am. Geriatr. Soc.

    (1995)
There are more references available in the full text version of this article.

Cited by (67)

  • Family Caregiver Perspectives on Suffering of Persons With Severe Dementia: A Qualitative Study

    2021, Journal of Pain and Symptom Management
    Citation Excerpt :

    A number of scales have been developed to measure suffering among patients, but only two specifically measure suffering among persons with dementia. These are the Mini Suffering-State Examination (MSSE) and the Suffering Scales.7,20 MSSE focuses specifically on assessing suffering among PWSDs.

  • The suffering measurement instruments in palliative care: A systematic review of psychometric properties

    2020, International Journal of Nursing Studies
    Citation Excerpt :

    A total of nine studies were included in this systematic review. One instrument (Mini-Suffering State Examination) was developed and validated in Israel (Adunsky et al., 2007; Aminoff et al., 2004), one (the Suffering Pictogram) in Malaysia (Beng et al., 2014; Beng et al., 2017), one (Pictorial Representation of Illness and Self-Measure) in the Netherlands and Colombia (Krikorian et al., 2013; Lehmann et al., 2011), one (Initial Assessment of Suffering) in Australia (MacAdam & Smith, 1987), one (State Of Suffering-Five) in the Netherlands only (Ruijs et al., 2009) and one (Suffering Assessment Questionnaire in Adults with Chronic Diseases or Life-Threatening Illness) in Portugal (Encarnação et al., 2018). All questionnaires were in English, except the Suffering Assessment Questionnaire in Adults with Chronic Diseases or Life-Threatening Illness, which was created in Portuguese.

  • Cross-cultural adaptation and psychometric testing of the Quality of Dying and Death Questionnaire for the Spanish population

    2018, European Journal of Oncology Nursing
    Citation Excerpt :

    These 10 items can be scored from 0 (no) to 1 (yes). A total score can be obtained by adding the individual score of each item, with a maximum possible score of 10 points (high level of suffering) (Aminoff et al., 2004). Although the MSSE was developed and validated in patients with advanced dementia, it can be used to evaluate the suffering in advanced cancer patients (Adunsky et al., 2007).

View all citing articles on Scopus
View full text